Vor Biopharma Inc. (VOR)
NASDAQ: VOR · Real-Time Price · USD
15.12
+0.56 (3.85%)
At close: Mar 6, 2026, 4:00 PM EST
14.68
-0.44 (-2.91%)
After-hours: Mar 6, 2026, 7:48 PM EST
Vor Biopharma Market Cap
Vor Biopharma has a market cap or net worth of $627.78 million as of March 6, 2026. Its market cap has increased by 259.36% in one year.
Market Cap
627.78M
Enterprise Value
460.38M
1-Year Change
259.36%
Ranking
Category
Stock Price
$15.12
Market Cap Chart
Since the IPO on February 5, 2021, Vor Biopharma's market cap has decreased from $1.30B to $627.78M, a decrease of -51.67%. That is a compound annual growth rate of -13.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 627.78M | 23.95% |
| Dec 31, 2025 | 506.46M | 266.35% |
| Dec 31, 2024 | 138.24M | -9.38% |
| Dec 29, 2023 | 152.56M | -65.05% |
| Dec 30, 2022 | 436.57M | 0.75% |
| Dec 31, 2021 | 433.30M | -66.64% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Theravance Biopharma | 687.62M |
| Tectonic Therapeutic | 673.52M |
| MiMedx Group | 668.55M |
| Replimune Group | 666.36M |
| AgomAb Therapeutics NV | 663.79M |
| Zura Bio | 661.28M |
| Jade Biosciences | 646.36M |
| Alto Neuroscience | 644.94M |